Congestive heart failure
Pro Research Analysisby 
Searched over 200M research papers
Congestive Heart Failure Overview and Prevalence
Congestive heart failure (CHF) is a major cardiovascular condition where the heart cannot pump enough blood to meet the body’s needs, leading to symptoms like fatigue, shortness of breath, and fluid congestion in tissues and organs Mercuro20192Mudd2008. In the United States, CHF affects millions, with estimates ranging from 1 to 5.8 million people, and its prevalence increases with age 2McKee1971Schocken1992. CHF is a leading cause of hospitalization, especially among those aged 65 and older, and is associated with high morbidity and mortality rates 2Mudd2008McKee1971+1 MORE.
Causes and Risk Factors for Congestive Heart Failure
The most common causes of CHF include hypertension, coronary heart disease, and diabetes 2McKee1971. Hypertension is the dominant precursor, preceding heart failure in the majority of cases, while coronary heart disease and rheumatic heart disease are also significant contributors . The risk and mortality from CHF are higher in men than women, and both increase with advancing age McKee1971Schocken1992.
Pathophysiology and Symptoms of CHF
CHF is characterized by progressive deterioration of left ventricular function, resulting in less blood circulating to body tissues and subsequent oxygen and nutrient deprivation Mercuro2019Mudd2008. As the heart’s pumping ability declines, the kidneys respond by retaining fluid and sodium, leading to fluid buildup (edema) in the hands, feet, abdomen, and sometimes the lungs, which can be life-threatening if untreated Mercuro2019Abassi2022. Common symptoms include severe fatigue, breathlessness, and swelling Mercuro2019Mudd2008Abassi2022.
Mechanisms of Edema Formation in CHF
Edema in CHF results from a complex interplay between the heart and kidneys. Reduced cardiac output activates neurohormonal systems such as the renin-angiotensin-aldosterone system (RAAS), sympathetic nervous system, and antidiuretic hormone, leading to sodium and water retention, vasoconstriction, and increased venous pressure . These changes cause fluid to accumulate in tissues, contributing to pulmonary and peripheral edema, and are often accompanied by elevated levels of natriuretic peptides, though these are insufficient to counteract the fluid retention Mercuro2019Abassi2022Coffey2012.
Molecular and Cellular Changes in CHF
CHF is associated with changes at the molecular level, including altered expression of gap junction proteins in the heart. Notably, there is a significant reduction in connexin43 in the left ventricle, which may contribute to arrhythmias and contractile dysfunction. Other connexins, such as connexin40, may increase as a compensatory response . These molecular changes can worsen the heart’s ability to function and increase the risk of life-threatening arrhythmias .
Advances in Detection and Monitoring of CHF
Recent advances in technology have improved CHF detection. Machine learning models, such as convolutional neural networks (CNNs) and long short-term memory (LSTM) networks, can accurately identify CHF using electrocardiogram (ECG) data or heart rate variability (HRV) from RR intervals Porumb2020Wang2019. These tools offer high accuracy and can be integrated into healthcare applications for continuous monitoring, supporting clinicians in early diagnosis and management Porumb2020Wang2019.
Prognosis and Mortality
Despite advances in understanding and treatment, CHF remains highly lethal. The probability of dying within five years of diagnosis is high, especially for men, and long-term mortality continues to rise with age McKee1971Schocken1992. As the population ages, the burden of CHF on healthcare systems is expected to increase Mudd2008Schocken1992.
Conclusion
Congestive heart failure is a common, serious condition with significant health impacts, especially among older adults. It is driven by underlying cardiovascular diseases, leads to complex physiological changes, and is associated with high rates of hospitalization and mortality. Advances in molecular understanding and detection technologies offer hope for better management, but the growing prevalence underscores the need for continued research and improved therapies Mercuro20192Porumb2020+7 MORE.
Sources and full results
Most relevant research papers on this topic